AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Voglisoor GM 2mg/500mg/0.3mg Tablet

Prescription Icon
Prescription Required

Marketer

Viswasoorya Pharmaceuticals

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Voglisoor GM 2mg/500mg/0.3mg Tablet

Diabexe Trio 2mg/500mg/0.3mg tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabexe Trio should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to hyperglycemia and potentially serious complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication is a component of a comprehensive diabetes management plan, including diet, exercise, and weight management as recommended by your doctor. The most frequent adverse effect is hypoglycemia. Familiarize yourself with its symptoms (sweating, dizziness, headache, tremors) and appropriate countermeasures. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, and your doctor might order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Voglisoor GM 2mg/500mg/0.3mg Tablet

No text provided to rephrase.

Uses of Voglisoor GM 2mg/500mg/0.3mg Tablet

Managing type 2 diabetes

Major Benefits of Voglisoor GM 2mg/500mg/0.3mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglisoor GM 2mg/500mg/0.3mg Tablet whole; do not chew, crush, or divide it. Administer this medication on an empty stomach.

Common Side effects of Voglisoor GM 2mg/500mg/0.3mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Voglisoor GM 2mg/500mg/0.3mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Voglisoor GM 2mg/500mg/0.3mg Tablets should be administered on an empty stomach.

How Voglisoor GM 2mg/500mg/0.3mg Tablet works:

Each Voglisoor GM tablet (2mg/500mg/0.3mg) contains a triple-action blend of antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Voglisoor GM 2mg/500mg/0.3mg Tablet with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Voglisoor GM 2mg/500mg/0.3mg Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Voglisoor GM 2mg/500mg/0.3mg Tablet while breastfeeding is likely inadvisable. Available evidence from humans indicates potential transfer to breast milk with a risk of infant harm.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if these conditions arise.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Voglisoor GM 2mg/500mg/0.3mg Tablets due to potential safety concerns. Medical advice is recommended. The use of Voglisoor GM 2mg/500mg/0.3mg Tablets is discouraged for individuals with severe kidney impairment.

LiverLiverCAUTION

Exercise caution when prescribing Voglisoor GM 2mg/500mg/0.3mg Tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. A reduced initial dose is typically recommended for patients exhibiting mild to moderate liver dysfunction; the medication is contraindicated in those with severe hepatic disease.

What if you forget to take Voglisoor GM 2mg/500mg/0.3mg Tablet :

Should you forget to take a Voglisoor GM 2mg/500mg/0.3mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Voglisoor GM 2mg/500mg/0.3mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Voglisoor GM 2mg/500mg/0.3mg Tablet

Voglisoor GM 2mg/500mg/0.3mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus (DM) in adults. This combination, used with diet and exercise, improves blood glucose control. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, while voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not for type 1 DM.
Voglisoor GM 2mg/500mg/0.3mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, taste changes, flatulence, stomach pain, headache, rash, and respiratory infections.
Voglisoor GM 2mg/500mg/0.3mg Tablets are contraindicated in patients allergic to any component, those with moderate-to-severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Voglisoor GM 2mg/500mg/0.3mg Tablet with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Voglisoor GM 2mg/500mg/0.3mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Voglisoor GM 2mg/500mg/0....
130
MRP 150
13% off